Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) SHH
7.22
-0.16(-2.17%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
7.22
-0.16(-2.17%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2545
First IPO Date
April 24, 2015
| Name | Title | Pay | Year Born |
| Jiujiang Yan | GM & Director | 0 | 1978 |
| Ji Lang | Investor Relations Director | 0 | N/A |
| Tianzhu Li | Deputy General Manager | 0 | 1978 |
| Zhongfang Zhang | Board Secretary | 0 | 1985 |
| Lei Wang | Chief Financial Officer & Accounting Supervisor | 0 | 1981 |
| Xiuzhen Li | Deputy General Manager | 0 | 1980 |
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.